To provide some solid data, the authors of the new study gave LSD to a group of patients in New Zealand, and instructed them ...

New research suggests that microdosing a popular psychedelic may provide relief for people struggling with major depressive ...

MindBio Therapeutics Corp. announced the results of its Phase 2B clinical trial investigating the effects of microdosed LSD on Major Depressive Disorder (MDD). The trial found that microdosed LSD did ...

University of Auckland researchers report that an 8-week, twice-weekly LSD microdosing regimen for major depressive disorder ...

Australian R&D company MindBio Therapeutics conducted a first-ever Phase 2a take-home microdosing trial to treat depression.. 53% of patients went into complete depression remission after 8 weeks of ...

A rigorous new study finds that a single dose of LSD can ease a person's anxiety for months. NPR's Jon Hamilton reports that the study shows how research on psychedelics is entering the mainstream.

LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned in the U.S. for ...

Millions struggle with depression and anxiety, often enduring long waits for effective treatment. Scientists in Sweden, ...